Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis
Thursday, January 16, 2020NuMedii Inc today announced a new partnership with a drug delivery company to develop new therapeutics for ulcerative colitis The collaboration will bring together NuMediis NM asset for ulcerative colitis and a proprietary delivery technology that en...
Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement
Monday, January 13, 2020Iovance Biotherapeutics Inc a latestage biotechnology company developing novel T cellbased cancer immunotherapies and Cellectis a clinicalstage biopharmaceutical company focused on developing immunotherapies based on geneedited allogeneic CAR TCells...
Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance® (palbociclib)
Monday, January 13, 2020Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional therapeutics today announced the initiation of a Phase trial evaluating ZW combination therapy and an agreement with Pfizer which advances the study Zymeworks HERtarg...
Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
Friday, January 10, 2020Almirall SA and WuXi Biologics have today announced the signing of an agreement Through this collaboration Almirall embarks on its strategy to develop highly innovative biologic products for dermatology diseases including atopic dermatitis
Evotec and Bayer Announce New Alliance Focusing on Drug Discovery for Polycystic Ovary Syndrome With Novel Targets From Celmatix
Friday, January 10, 2020Evotec SE and Bayer AG today announced the expansion of their partnership in womens health indications with a new fiveyear multitarget collaboration with participation from Celmatix Inc to develop multiple clinical candidates for the treatment of pol...
Schrödinger and Bayer collaborate to co- develop de novo design technology and accelerate drug discovery
Thursday, January 09, 2020Schrdinger and Bayer today announce a fiveyear technology alliance to develop a de novo comprehensive design solution with the goal of accelerating the discovery of innovative and highquality drugs quality The technology should make it possible to li...
Targovax and IOVaxis Therapeutics Enters Option Agreement for TG Mutant RAS Vaccine License and Clinical Development in China
Thursday, January 09, 2020Targovax ASA a clinical stage immunooncology company developing oncolytic viruses and cancer vaccines to target hardtotreat solid tumors today announces that it has entered into an exclusive option agreement with IOVaxis Therapeutics of Nantong China...
Curis Announces Option and License Agreement with ImmuNext
Wednesday, January 08, 2020Curis Inc a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer today announced that it has entered into an option and license agreement to acquire exclusive worldwide rights from ImmuNext Inc ImmuN...
SAB Biotherapeutics Announces Research Collaboration With CSL Behring
Wednesday, January 08, 2020SAB Biotherapeutics SAB a clinicalstage biopharmaceutical development company advancing a new class of immunotherapies today announced that it has entered into multiple collaboration and option agreements with global biotherapeutics leader CSL Behrin...
Galecto and PharmAkea Merge to Create Strong Clinical-Stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer
Wednesday, January 08, 2020Galecto the leading developer of galectin modulators for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis IPF and cancer and PharmAkea Inc a privately held San Diegobased pharmaceutical company developing novel small molecul...
